BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) Net Income by Year
BriaCell Therapeutics Corp. Warrant expiring 2031 reported a net loss of $26.3M in fiscal year 2025. This represents a decrease of 449.1% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters BriaCell Therapeutics Corp. Warrant expiring 2031 has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BCTXL Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BCTXL Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More BriaCell Therapeutics Corp. Warrant expiring 2031 financials
Frequently Asked Questions
What was BriaCell Therapeutics Corp. Warrant expiring 2031's net income in fiscal year 2025?
BriaCell Therapeutics Corp. Warrant expiring 2031 reported a net loss of $26.3M in fiscal year 2025.
How fast is BriaCell Therapeutics Corp. Warrant expiring 2031's net income growing?
BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) net income fell by 449.1% year over year, from -$4.8M to -$26.3M in fiscal year 2025.
How has BriaCell Therapeutics Corp. Warrant expiring 2031's net income changed over the years?
Across the 5 fiscal years this page covers, BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) net income went from -$13.8M in fiscal year 2021 to -$26.3M in fiscal year 2025.
What was BriaCell Therapeutics Corp. Warrant expiring 2031's net income in the most recent quarter?
BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) reported -$7.2M in net income in Q3 2026. This represents a decrease of 16.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) reported on that line in every period on record.